We are live on ! Find out more
IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
1-Year Est. Return 48.5%
This Fund
S&P 500
This Quarter Est. Return
+61.55%
1 Year Est. Return
+48.5%
3 Year Est. Return
-57.65%
5 Year Est. Return
-76.52%
10 Year Est. Return
–
AUM
$121M
AUM Growth
+$25.9M
Cap. Flow
-$19.9M
Cap. Flow %
-16.52%
Top 10 Hldgs %
99.96%
Holding
12
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$13.7M
2
MGNX icon
MacroGenics
MGNX
+$6.25M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 54.67%
2 Healthcare 45.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REAL icon
1
The RealReal
REAL
$1.4B
$65.9M 54.67%
5,154,080
– –
GKOS icon
2
Glaukos
GKOS
$8.92B
$24.8M 20.59%
646,364
-367,000
-36% -$13.7M
AGTC
3
DELISTED
Applied Genetic Technologies Corporation
AGTC
$8.07M 6.69%
1,455,904
– –
EIGR
4
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$7.34M 6.09%
25,497
– –
CDTX
5
DELISTED
Cidara Therapeutics
CDTX
$5.01M 4.15%
67,841
– –
KALV
6
DELISTED
KalVista Pharmaceuticals
KALV
$4.7M 3.9%
388,766
– –
VERO
7
DELISTED
Venus Concept
VERO
$2.3M 1.91%
3,992
– –
STIM icon
8
Neuronetics
STIM
$126M
$1.99M 1.65%
1,030,689
– –
HIND
9
Vyome Holdings
HIND
$14M
– –
0
– –
XENE icon
10
Xenon Pharmaceuticals
XENE
$6.36B
$104K 0.09%
8,293
– –
DARE icon
11
Dare Bioscience
DARE
$19.8M
$50K 0.04%
4,197
– –
MGNX icon
12
MacroGenics
MGNX
$254M
– –
-1,074,316
Closed -$6.25M

Similar funds

RCP
Rho Capital Partners New York $20.4M AUM
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

InterWest Venture Management's Q2 2020 Portfolio in Review

As of Q2 2020, InterWest Venture Management held 12 positions worth $121M, up 27% from $94.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

InterWest Venture Management withdrew a net $19.9M in Q2 2020, closing 1 position and reducing 1 holding. Its most notable exit was MacroGenics, an estimated $6.25M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 55% of assets, up from 38% a quarter earlier, followed by Healthcare.

  • InterWest Venture Management's biggest Q2 2020 reduction was Glaukos, cutting an estimated $13.7M.
  • InterWest Venture Management fully exited MacroGenics in Q2 2020, selling an estimated $6.25M.
  • InterWest Venture Management's ten largest holdings make up 100% of its $121M portfolio in Q2 2020.
  • InterWest Venture Management opened 0 new positions and closed 1 in Q2 2020.
  • InterWest Venture Management's portfolio value rose 27% quarter-over-quarter to $121M.

Based on InterWest Venture Management's 13F filing for Q2 2020, filed 23 Jul 2020.